International Journal of Biomedical Imaging
Volume 2007 (2007), Article ID 63234, 4 pages
doi:10.1155/2007/63234
Research Article

Kidney Modelling for FDG Excretion with PET

Huiting Qiao,1 Jing Bai,1 Yingmao Chen,2 and Jiahe Tian2

1Department of Biomedical Engineering, Tsinghua University, Beijing 100084, China
2Department of Nuclear Medicine, General Hospital of PLA, Beijing 100853, China

Received 18 January 2007; Accepted 31 May 2007

Academic Editor: Jie Tian

Copyright © 2007 Huiting Qiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Gallagher, A. Ansari, and H. Atkins, et al., “Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals,” Journal of Nuclear Medicine, vol. 18, no. 10, pp. 990–996, 1977.
  2. S. C. Huang, M. E. Phelps, E. J. Hoffman, K. Sideris, C. J. Selin, and D. E. Kuhl, “Noninvasive determination of local cerebral metabolic rate of glucose in man,” The American Journal of Physiology, vol. 238, no. 1, pp. E69–E82, 1980.
  3. T. Torizuka, K. R. Zasadny, B. Recker, and R. L. Wahl, “Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies,” Radiology, vol. 207, no. 3, pp. 767–774, 1998.
  4. T. Torizuka, S. Nobezawa, and S. Momiki, et al., “Short dynamic FDG-PET imaging protocol for patients with lung cancer,” European Journal of Nuclear Medicine, vol. 27, no. 10, pp. 1538–1542, 2000. View at Publisher · View at Google Scholar
  5. M. T. Hays and G. M. Segall, “A mathematical model for the distribution of fluorodeoxyglucose in humans,” Journal of Nuclear Medicine, vol. 40, no. 8, pp. 1358–1366, 1999.
  6. J. K. Moran, H. B. Lee, and M. D. Blaufox, “Optimization of urinary FDG excretion during PET imaging,” Journal of Nuclear Medicine, vol. 40, no. 8, pp. 1352–1357, 1999.
  7. L. G. Bouchet, W. E. Bolch, and H. P. Blanco, et al., “MIRD Pamphlet No. 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney,” Journal of Nuclear Medicine, vol. 44, no. 7, pp. 1113–1147, 2003.
  8. Z. Szabo, J. Xia, W. B. Mathews, and P. R. Brown, “Future direction of renal positron emission tomography,” Seminars in Nuclear Medicine, vol. 36, no. 1, pp. 36–50, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. G. Germano, B. C. Chen, S.-C. Huang, S. S. Gambhir, E. J. Hoffman, and M. E. Phelps, “Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies,” Journal of Nuclear Medicine, vol. 33, no. 4, pp. 613–620, 1992.
  10. P. Shreve, P.-C. Chiao, H. D. Humes, M. Schwaiger, and M. D. Gross, “Carbon-11-acetate PET imaging in renal disease,” Journal of Nuclear Medicine, vol. 36, no. 9, pp. 1595–1601, 1995.
  11. A. Bertoldo, P. Vicini, G. Sambuceti, A. A. Lammertsma, O. Parodi, and C. Cobelli, “Evaluation of compartmental and spectral analysis models of [F18]FDG kinetics for heart and brain studies with PET,” IEEE Transactions on Biomedical Engineering, vol. 45, no. 12, pp. 1429–1448, 1998. View at Publisher · View at Google Scholar
  12. J. S. Fowler, J. Logan, and G.-J. Wang, et al., “PET imaging of monoamine oxidase B in peripheral organs in humans,” Journal of Nuclear Medicine, vol. 43, no. 10, pp. 1331–1338, 2002.